Volker Huppert

Chief Development Officer, Glycostem Therapeutics

1990 - 1996 Studies of Bioprocess Engineering, RWTH Aachen, Germany 1996 - 2018 Miltenyi Biotec GmbH, Research & Development, Bergisch Gladbach, Germany Clinical grade cell separation and cell culture, Hematopoietic Stem Cells, Natural Killer Cells, "Graft Engineering" / Stem Cell Transplantation, "closed system", NK cell transduction, Stem Cell Transduction, CliniMACS plus and Prodigy Cell Processing Systems 2018 ff. Glycostem Therapeutics B.V., Oss, The Netherlands Cord Blood Hematopoietic Stem Cell derived Natural Killer Cells GMP Setup and Introduction, Closed System, Process Development, Scaling